Investor Relations

Princeton, N.J. – – September 15, 2026 -- CytoSorbents Corporation (NASDAQ: CTSO) will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York City from September 14–16, 2026, as the blood-purification device maker seeks to update investors on its regulatory pipeline and path to profitability.

CEO and CFO to join fireside chat on September 14

Dr. Phillip Chan, Chief Executive Officer, and Peter Mariani, Chief Financial Officer, will join Sean Lee, Vice President of Equity Research at H.C. Wainwright, for a fireside chat at 11:30 a.m. EDT at the Lotte New York Palace Hotel. The two executives will also hold scheduled one-on-one meetings with investors during the three-day event. A webcast replay will remain archived for up to 90 days on the company's investor relations site.

Indianapolis – September 15, 2026 -- Elanco Animal Health Incorporated (NYSE: ELAN) confirmed its leadership team will participate in the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026.

Top executives to field investor questions in fireside chat format

CEO Jeff Simmons, CFO Bob VanHimbergen, and Bobby Modi, executive vice president for U.S. Pet Health and Global Digital Transformation, will join a fireside chat session scheduled for 2:35 p.m. ET on September 15.

Digital transformation leadership signals strategic pivot in pet health segment

Modi's dual role overseeing both U.S. Pet Health operations and Global Digital Transformation places technology investment discussions on the agenda alongside core business performance.